Despite advances in cancer treatment in recent years, five-year survival rates for acute myeloid leukemia (AML) remain low at just 30% on average, according to the National Cancer Institute. Factors ...

Scientists at VCU Massey Comprehensive Cancer Center have identified an innovative combination of treatment strategies that work collaboratively to effectively kill acute myeloid leukemia (AML) cells, ...

Children with Down syndrome have a significantly increased risk of leukemia, while adults have a lower risk of several common ...

A new study has identified taurine, a naturally occurring amino acid, as a critical factor in the growth of certain types of leukemia. It was published on May 14 in the journal Nature. They said the ...

The blood cancers acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) are extremely challenging to treat. While advances in immunotherapy have cured many patients with other blood cancers, ...